S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands

Immix Biopharma (IMMX) News Today

$3.35
-0.35 (-9.46%)
(As of 02/29/2024 ET)
SourceHeadline
MarketBeat logoImmix Biopharma, Inc. (NASDAQ:IMMX) Short Interest Update
americanbankingnews.com - March 1 at 5:22 AM
msn.com logoImmix Biopharma (IMMX) Price Target Increased by 27.27% to 14.28
msn.com - February 24 at 11:20 PM
finance.yahoo.com logoIMMX Apr 2024 7.500 call
finance.yahoo.com - February 22 at 7:52 PM
finanznachrichten.de logoImmix Biopharma, Inc.: Immix Biopharma 12 Month Review Progress Update
finanznachrichten.de - February 21 at 2:15 PM
markets.businessinsider.com logoImmix Biopharma 12 Month Review Progress Update
markets.businessinsider.com - February 21 at 2:15 PM
finance.yahoo.com logoImmix Biopharma 12 Month Review Progress Update
finance.yahoo.com - February 21 at 2:15 PM
globenewswire.com logoImmix Biopharma 12 Month Review Progress Update
globenewswire.com - February 21 at 9:31 AM
finance.yahoo.com logoIMMX Aug 2024 2.500 call
finance.yahoo.com - February 13 at 7:56 AM
finance.yahoo.com logoImmix Biopharma Announces Closing of $15 Million Public Offering of Common Stock
finance.yahoo.com - February 8 at 7:18 PM
finanznachrichten.de logoImmix Biopharma, Inc.: Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis
finanznachrichten.de - February 8 at 2:17 PM
markets.businessinsider.com logoImmix Biopharma Signs Definitive $15M Titan Partnership Deal
markets.businessinsider.com - February 7 at 12:40 PM
finance.yahoo.com logoImmix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis
finance.yahoo.com - February 7 at 12:40 PM
msn.com logoImmix Biopharma Suspends Stock Offering Pending New Prospectus
msn.com - February 6 at 10:20 AM
finance.yahoo.com logoImmix Biopharma Announces Pricing of $15 Million Public Offering of Common Stock
finance.yahoo.com - February 5 at 11:42 PM
finance.yahoo.com logoImmix Biopharma Announces Proposed Public Offering of Common Stock
finance.yahoo.com - February 5 at 6:41 PM
marketbeat.com logo
marketbeat.com - February 5 at 3:35 PM
marketbeat.com logo
marketbeat.com - February 5 at 3:35 PM
markets.businessinsider.com logoImmix Biopharma Reveals FDA Labeling Change Notification For CAR-T Products
markets.businessinsider.com - January 24 at 7:27 PM
finanznachrichten.de logoImmix Biopharma, Inc.: Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products
finanznachrichten.de - January 24 at 2:27 PM
finance.yahoo.com logoImmix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products
finance.yahoo.com - January 24 at 2:27 PM
marketbeat.com logoImmix Biopharma, Inc. (NASDAQ:IMMX) Sees Large Increase in Short Interest
marketbeat.com - January 15 at 2:56 AM
marketbeat.com logoShort Interest in Immix Biopharma, Inc. (NASDAQ:IMMX) Expands By 52.3%
marketbeat.com - January 13 at 8:35 AM
finance.yahoo.com logoIs Immix Biopharma (NASDAQ:IMMX) In A Good Position To Invest In Growth?
finance.yahoo.com - January 11 at 8:48 AM
finance.yahoo.com logoImmix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board
finance.yahoo.com - January 4 at 10:11 AM
finance.yahoo.com logoImmix Biopharma Announces Dr. Marko Radic, Autoimmune CAR-T Pioneer and Associate Professor at the University of Tennessee Health Science Center, Joins Scientific Advisory Board
finance.yahoo.com - December 18 at 1:12 PM
finance.yahoo.com logoInsider Spends US$267k Buying More Shares In Immix Biopharma
finance.yahoo.com - December 15 at 9:13 AM
finance.yahoo.com logoImmix Biopharma Announces 100% Overall Response Rate (n=10); 23.7 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2023
finance.yahoo.com - December 11 at 2:02 PM
finance.yahoo.com logoImmix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit
finance.yahoo.com - November 30 at 10:39 AM
finance.yahoo.com logoWhat Makes Immix Biopharma, Inc. (IMMX) a Good Fit for 'Trend Investing'
finance.yahoo.com - November 28 at 4:16 PM
finance.yahoo.com logoPleasing Signs As A Number Of Insiders Buy Immix Biopharma Stock
finance.yahoo.com - November 24 at 9:15 AM
msn.com logoImmix to assess cell therapy in Phase Ib/IIa AL amyloidosis trial
msn.com - November 22 at 2:48 PM
finance.yahoo.com logoImmix Biopharma to Host KOL Event to Discuss its BCMA-Targeted CAR-T Cell Therapy Candidate NXC-201 for Relapsed/Refractory AL Amyloidosis
finance.yahoo.com - November 22 at 2:48 PM
msn.com logoFDA okays US clinical testing for Immix drug NXC-201
msn.com - November 21 at 2:33 PM
markets.businessinsider.com logoImmix Biopharma Announces FDA IND Clearance For CAR-T NXC-201
markets.businessinsider.com - November 21 at 2:33 PM
finance.yahoo.com logoImmix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing
finance.yahoo.com - November 21 at 2:33 PM
finance.yahoo.com logoImmix Biopharma Presents NXC-201 Data at 65th American Society of Hematology (ASH) Annual Meeting in 63 Relapsed/Refractory Multiple Myeloma Patients
finance.yahoo.com - November 6 at 1:05 PM
finance.yahoo.com logoImmix Biopharma Presents NXC-201 Data at 65th American Society of Hematology (ASH) Annual Meeting in 9 Relapsed/Refractory AL Amyloidosis Patients
finance.yahoo.com - November 6 at 1:05 PM
finance.yahoo.com logoHere's Why Immix Biopharma, Inc. (IMMX) Is a Great 'Buy the Bottom' Stock Now
finance.yahoo.com - October 31 at 12:34 PM
finance.yahoo.com logoImmix Biopharma Subsidiary Nexcella Announces Dr. Michaela Liedtke, Stanford Medicine Cancer Center Hematology Program Lead and Co-Director Stanford Amyloid Center, Joins Scientific Advisory Board
finance.yahoo.com - October 26 at 10:12 AM
finance.yahoo.com logoImmix Biopharma Completes 3rd NXC-201 Engineering Batch at its U.S. CAR-T Manufacturing Site
finance.yahoo.com - October 16 at 12:53 PM
finance.yahoo.com logoImmix Biopharma Announces Complete Response in 9th Relapsed/Refractory AL Amyloidosis Patient in NXC-201 Clinical Trial at IMS 20th Annual Meeting
finance.yahoo.com - October 3 at 1:37 PM
marketbeat.com logo
marketbeat.com - October 3 at 9:37 AM
msn.com logoWhat's Going On With Cancer-Focused Immix Biopharma Stock Today?
msn.com - October 2 at 4:06 PM
finance.yahoo.com logoImmix Biopharma Announces 72-Patient NXC-201 Clinical Data at the IMS 20th Annual Meeting, 95% Overall Response Rate in Multiple Myeloma
finance.yahoo.com - October 2 at 10:48 AM
msn.com logoImmix Biopharma files to sell 5.15M shares of common stock for holders
msn.com - September 25 at 7:25 PM
finance.yahoo.com logoU.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Amyloid Light Chain (AL) Amyloidosis
finance.yahoo.com - September 21 at 1:04 PM
msn.com logoImmix Biopharma director acquires $2M worth of shares
msn.com - September 19 at 6:37 PM
benzinga.com logoDirector of Immix Biopharma Purchased $200K In Stock
benzinga.com - September 19 at 1:36 PM
finance.yahoo.com logoImmix Biopharma Subsidiary Nexcella Completes 2nd NXC-201 Engineering Batch at its U.S. CAR-T Manufacturing Site
finance.yahoo.com - September 19 at 1:36 PM
finance.yahoo.com logoDirector Helen Adams Buys 13,000 Shares of Immix Biopharma Inc (IMMX)
finance.yahoo.com - September 15 at 5:35 PM
Get Immix Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMMX and its competitors with MarketBeat's FREE daily newsletter.



IMMX Media Mentions By Week

IMMX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMMX
News Sentiment

0.85

0.60

Average
Medical
News Sentiment

IMMX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMMX Articles
This Week

4

1

IMMX Articles
Average Week

Get Immix Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMMX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:IMMX) was last updated on 3/1/2024 by MarketBeat.com Staff